EHF and cancer: This establishes a novel IR-JMJD6-EHF signaling axis in EHF, once transcriptionally activated by JMJD6, acts as a pioneer factor that opens up chromatin and facilitates the expression of a broader network of genes involved in cancer cell stemness and survival.